Pinkas Lebovits, M.D.
NPI 1023015245 · Specialist · New York, NY
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Pinkas Lebovits, M.D. is a Specialist provider in New York, NY (NPI 1023015245).
Provider details
- NPI number
- 1023015245
- Entity type
- Individual
- Primary specialty
- SpecialistOther Service Providers
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- Yes
- License
- 136484 (NY)
Specialties & taxonomies
Other Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
5,725 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 2,924 | $8 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 911 | $105 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 470 | $54 |
| Biopsy of Related Skin Growth, First Growth11102 | 337 | $95 |
| Destruction of Skin Growth, 1-14 Growths17110 | 270 | $130 |
| Biopsy of Related Skin Growth, Each Additional Growth |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 64 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ketoconazole | 2,595 | 706 |
| Ammonium Lactate | 2,150 | 830 |
| Triamcinolone Acetonide | 1,259 | 704 |
| Fluocinonide | 981 | 157 |
| Mometasone Furoate | 920 | 346 |
| Tretinoin | 781 | 265 |
| Clobetasol Propionate | 725 | 237 |
| Metronidazole | 603 | 217 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$584 across 28 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-07-01
- Last updated
- 2007-10-30
Frequently asked questions
- What is Pinkas Lebovits's NPI number?
- Pinkas Lebovits's National Provider Identifier (NPI) is 1023015245, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Pinkas Lebovits's specialty?
- Pinkas Lebovits is listed in the NPPES registry with a primary specialty of Specialist (Other Service Providers).
- Where is Pinkas Lebovits located?
- Pinkas Lebovits's practice location on file with NPPES is 200 W 58th St, New York, NY 10019-1432.
- What is Pinkas Lebovits's phone number?
- The practice phone number listed in the NPPES registry for Pinkas Lebovits is (212) 757-7010.
- Does Pinkas Lebovits accept Medicare?
- Pinkas Lebovits is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Pinkas Lebovits's NPI active?
- Yes — Pinkas Lebovits's NPI (1023015245) is active in the NPPES registry as of the last update on 2007-10-30.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.